These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9730150)

  • 81. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
    Pauleit D; Schüller H; Textor J; Leutner C; Keller E; Sommer T; Träber F; Block W; Boldt I; Schild H
    Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The ophthalmopathy of Graves' disease.
    Carter JA; Utiger RD
    Annu Rev Med; 1992; 43():487-95. PubMed ID: 1580604
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Preventing Graves' ophthalmopathy.
    Wiersinga WM
    N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
    [No Abstract]   [Full Text] [Related]  

  • 84. [The effects of intensive DMPA regimen in the treatment of Graves' ophthalmopathy].
    Wei S; Tong N; Luo Q; Tian H; Yu Y; Liu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):306-9. PubMed ID: 9389069
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Combined immunosuppressants and less steroids in active graves' orbitopathy?
    Salvi M; Covelli D
    Clin Endocrinol (Oxf); 2019 Apr; 90(4):525-527. PubMed ID: 30549306
    [TBL] [Abstract][Full Text] [Related]  

  • 86. An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy.
    Teng CS; Crombie AL; Hall R; Ross WM
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):545-51. PubMed ID: 6784979
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Graves' ophthalmopathy--a clinical review.
    Carter JN
    Aust N Z J Ophthalmol; 1990 Aug; 18(3):239-42. PubMed ID: 2261168
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Squint surgery in patients with Graves' ophthalmopathy.
    Maillette de Buy Wenniger-Prick LJ; Van Mourik-Noordenbos AM; Koornneef L
    Doc Ophthalmol; 1986 Jan; 61(3-4):219-21. PubMed ID: 3753926
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy.
    Glinoer D; Etienne-Decerf J; Schrooyen M; Sand G; Hoyoux P; Mahieu P; Winand R
    Acta Endocrinol (Copenh); 1986 Jan; 111(1):30-8. PubMed ID: 2868602
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Radiotherapy for moderate-to-severe Graves' ophthalmopathy: improved outcomes with early treatment.
    Alpert TE; Alpert SG; Bersani TA; Hahn SS; Bogart JA; Chung CT
    Cancer J; 2003; 9(6):472-5. PubMed ID: 14740976
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Treatment of Graves' ophthalmopathy with cyclosporin A.
    Witte A; Landgraf R; Markl A; Boergen KP; Hasenfratz G; Pickardt CR
    Klin Wochenschr; 1985 Oct; 63(19):1000-4. PubMed ID: 3840854
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Restricted motility for vertical strabismus in Graves' ophthalmopathy.
    Cruz OA
    Ophthalmology; 2001 Feb; 108(2):242-3. PubMed ID: 11158789
    [No Abstract]   [Full Text] [Related]  

  • 93. Radiation therapy for Graves' ophthalmopathy: a retrospective analysis.
    Palmer D; Greenberg P; Cornell P; Parker RG
    Int J Radiat Oncol Biol Phys; 1987 Dec; 13(12):1815-20. PubMed ID: 3679918
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cyclophosphamide in the management of advanced Graves' ophthalmopathy. A preliminary report.
    Bigos ST; Nisula BC; Daniels GH; Eastman RC; Johnston HH; Kohler PO
    Ann Intern Med; 1979 Jun; 90(6):921-3. PubMed ID: 582090
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Graves' ophthalmopathy: a rational approach to treatment.
    Wiersinga WM; Prummel MF
    Trends Endocrinol Metab; 2002 Sep; 13(7):280-7. PubMed ID: 12163229
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Clinical classification of Graves' ophthalmopathy. Identification of risk factors for optic neuropathy.
    Feldon SE; Muramatsu S; Weiner JM
    Arch Ophthalmol; 1984 Oct; 102(10):1469-72. PubMed ID: 6548373
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Low- vs. high-dose radiotherapy in Graves' ophthalmopathy: a retrospective comparison of long-term results.
    Weissmann T; Lettmaier S; Donaubauer AJ; Bert C; Schmidt M; Kruse F; Ott O; Hecht M; Fietkau R; Frey B; Putz F
    Strahlenther Onkol; 2021 Oct; 197(10):885-894. PubMed ID: 33860819
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Radiation therapy for Graves' disease.
    Brennan MW; Leone CR; Janaki L
    Am J Ophthalmol; 1983 Aug; 96(2):195-9. PubMed ID: 6688326
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Positional effects on exophthalmometer readings in Graves' eye disease.
    Frueh BR; Garber F; Grill R; Musch DC
    Arch Ophthalmol; 1985 Sep; 103(9):1355-6. PubMed ID: 3840014
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Immunosuppressive treatment of Graves' ophthalmopathy.
    Wiersinga WM
    Trends Endocrinol Metab; 1990; 1(8):377-81. PubMed ID: 18411147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.